Francois Venter Selected Research

Francois Venter Research Topics

4	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 10/2007
4	Weight Gain 03/2022 - 01/2020
3	COVID-19 10/2023 - 01/2021
3	Neural Tube Defects (Exencephaly) 01/2020 - 01/2018
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2023 - 01/2017
2	Obesity 01/2023 - 01/2022
2	Tuberculosis (Tuberculoses) 01/2018 - 01/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2014 - 12/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Abdominal Obesity 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Coinfection 01/2018
1	HIV Infections (HIV Infection) 11/2017
1	Exanthema (Rash) 11/2008
1	Drug-Related Side Effects and Adverse Reactions 11/2008
1	Lactic Acidosis 12/2007
1	Anemia 12/2007
1	Hypersensitivity (Allergy) 12/2007
1	Pancreatitis 12/2007

7	dolutegravirIBA 01/2023 - 01/2018
3	Integrase InhibitorsIBA 01/2023 - 02/2019
2	AntigensIBA 10/2023 - 01/2023
2	cabotegravirIBA 01/2023 - 01/2021
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 03/2022 - 12/2021
2	efavirenz (Sustiva)FDA Link 03/2022 - 12/2021
2	Stavudine (Zerit)FDA LinkGeneric 11/2008 - 12/2007
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	RacivirIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	HDL CholesterolIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Rilpivirine (TMC-278)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2018
1	LipidsIBA 11/2017
1	Contraceptive Agents (Contraceptives)IBA 01/2017
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2015
1	Lamivudine (Epivir)FDA Link 11/2008
1	Nevirapine (Viramune)FDA Link 11/2008
1	Didanosine (Videx)FDA LinkGeneric 12/2007
1	EnzymesIBA 12/2007

5	Therapeutics 01/2022 - 01/2014
3	Art Therapy 01/2024 - 02/2019
2	Self-Testing 01/2023 - 01/2021
1	Postcoital Contraception (Emergency Contraception) 01/2023
1	Injections 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 10/2007